OR WAIT null SECS
March 11, 2022
C4 Therapeutics has been granted orphan drug designation by FDA for CFT8634 for the treatment of soft tissue sarcoma.
SCG Cell Therapy has signed a collaboration agreement with A*STAR’s BTI to advance the development of antibodies for infectious diseases and cancer treatments.
Biotech companies and medical product manufacturers have condemned the invasion of Ukraine, while also looking to maintain supplies of essential medicines.
Novartis will pay Voyager up to $1.75 billion for access to Voyager’s novel Tracer AAV capsids for potential use with three CNS targets.
Various executives in the life sciences industry have started a petition calling for “complete economic disengagement” with Russia.
March 10, 2022
Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.
Evonik has launched new EUDRATEC technology to improve solubility and performance of oral small molecules.
Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.
UCB has announced it will build a new innovative gene therapy facility in Belgium.
March 09, 2022
Spectrum Chemical has further expanded its bioCERTIFIED product portfolio to support the growing global demand for new vaccines and therapeutics.